Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of sickle cell gene therapy ...

Sickle cell disease commonly affects people of African and Caribbean backgrounds and can be life-threatening but campaigners and experts say it isn't treated equally to other blood disorders because o ...

Sickle cell anemia, first described in 1910, primarily affects people of African, Mediterranean and Middle Eastern descent.